UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2009-01, Vol.43 (1), p.49-54

2009

Volltextzugriff (PDF)

Characteristics of chronic GVHD after cord blood transplantation

Bone marrow transplantation (Basingstoke), 2013-10, Vol.48 (10), p.1285-1290

2013

Volltextzugriff (PDF)

Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity

Bone marrow transplantation (Basingstoke), 2016-10, Vol.51 (10), p.1350-1353

2016

Volltextzugriff (PDF)

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

Bone marrow transplantation (Basingstoke), 2016-12, Vol.51 (12), p.1573-1578

2016

Volltextzugriff (PDF)

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD

Bone marrow transplantation (Basingstoke), 2009-12, Vol.44 (11), p.739-748

2009

Volltextzugriff (PDF)

Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.315-316

2014

Volltextzugriff (PDF)

Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2003-09, Vol.32 (5), p.515-522

2003

Volltextzugriff (PDF)

Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2007-11, Vol.40 (10), p.965-971

2007

Volltextzugriff (PDF)

Implications of early airflow decline after myeloablative allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2004-04, Vol.33 (7), p.759-764

2004

Volltextzugriff (PDF)

Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens

Bone marrow transplantation (Basingstoke), 2008-05, Vol.41 (10), p.887-893

2008

Volltextzugriff (PDF)

Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2005-08, Vol.36 (4), p.337-341

2005

Volltextzugriff (PDF)

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

Haematologica (Roma), 2015-06, Vol.100 (6), p.842-848

2015

Volltextzugriff (PDF)

Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (3), p.337-346

2004

Volltextzugriff (PDF)

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

Bone marrow transplantation (Basingstoke), 2005-02, Vol.35 (3), p.277-282

2005

Volltextzugriff (PDF)

Low‐dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA‐matched related donors in patients with Fanconi anaemia

British journal of haematology, 2005-07, Vol.130 (1), p.99-106

2005

Volltextzugriff (PDF)

High Rates of Pneumocystis carinii Pneumonia in Allogeneic Blood and Marrow Transplant Recipients Receiving Dapsone Prophylaxis

Clinical infectious diseases, 1999-12, Vol.29 (6), p.1467-1471

1999

Volltextzugriff (PDF)

Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning

Journal of clinical oncology, 2005-03, Vol.23 (9), p.1993-2003

2005

Volltextzugriff (PDF)

Recovery of normal autologous myelopoiesis after graft rejection following allogeneic bone marrow transplant for agnogenic myeloid metaplasia

Clinical and laboratory haematology, 2006-04, Vol.28 (2), p.134-137

2006

Volltextzugriff (PDF)

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia

Haematologica (Roma), 2011-08, Vol.96 (8), p.1113-1120

2011

Volltextzugriff (PDF)

Nocardiosis After Bone Marrow Transplantation: A Retrospective Study

Clinical infectious diseases, 1997-06, Vol.24 (6), p.1154-1160

1997

Volltextzugriff (PDF)

A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients

Blood, 1999-10, Vol.94 (7), p.2192-2199

1999

Volltextzugriff (PDF)

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Haematologica (Roma), 2014-10, Vol.99 (10), p.1624-1631

2014

Volltextzugriff (PDF)

Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease

Haematologica (Roma), 2015-05, Vol.100 (5), p.690-695

2015

Volltextzugriff (PDF)

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

Blood, 2009-05, Vol.113 (20), p.4992-5001

2009

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(206)

Publikationsform

Artikel
(230)

Sprache

Englisch
(230)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

Characteristics of chronic GVHD after cord blood transplantation

Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

Therapy with mycophenolate mofetil for refractory acute and chronic GVHD

Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions

Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation

Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation

Implications of early airflow decline after myeloablative allogeneic stem cell transplantation

Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens

Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

Low‐dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA‐matched related donors in patients with Fanconi anaemia

High Rates of Pneumocystis carinii Pneumonia in Allogeneic Blood and Marrow Transplant Recipients Receiving Dapsone Prophylaxis

Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning

Recovery of normal autologous myelopoiesis after graft rejection following allogeneic bone marrow transplant for agnogenic myeloid metaplasia

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia

Nocardiosis After Bone Marrow Transplantation: A Retrospective Study

A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

Aktive Filter

Suchergebnisse filtern